1Boulanger E, Wautier JL, Dequiedt P, et al. Glycation, glycoxidation and diabetes mellitus[J].Nephrol Ther, 2006,2 (Suppl 1):S8-16.
2Yamamoto T,Shibata N, Muramatsu F, et al. Oxidative stress in the human fetal brain: an immunohistochemical study[J]. Pediatr Neurol,2002,26(2) :116-122.
3Ma L, Carter RJ, Morton AJ, et al. RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats[J]. Brain Res, 2003,966 (2):167-174.
4Schmidt AM, Yan SD, Yan SF, et al. The biology of the receptor for advanced glycation end products and its Ligands [J]. BiochimBiophys Acta,2000,1498(2/3):99-111.
5Nishi T,Maier CM, Hayashi T, et al. Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia[J]. J Cereb Blood Flow Metab, 2005,25(10) : 1312-1324.
6Sullivan KA, Feldman EL. New developments in diabetic neuropathy[J].Curr Opin Neurol,2005,18(5) :586-590.
7Laneler HM, Tauras JM, Ogiste JS, et al. Activation of the receptor for advanced glycation end products triggers a p21 (ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress[J]. Biol Chem, 1997,272 (28): 17810-17814.
8Niiya Y, Abumiya T, Shiehinohe H, et al. Susceptibility of brain mierovaseular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species[J]. Brain Res, 2006,1108 (1) :179-187.
9Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications [J]. Physiol Res, 2004,53 (2) : 131-142.
10Teles R,Ferreira J,Aguiar C,et al. Prognostic value of cardiac troponin release kinetics in unstable angina [J]. Rev Port Cardiol, 2000,19 (4) : 407-422.
4[1]Heller GV.Evaluation of the patient with diabetes mellitus and suspected coronary artery disease[J].Am J Med,2005,118[Suppl 2]:9S-14.
5[2]Grundy SM,Benjamin IJ,Burke GL,et al.Diabetes and cardiovascular disease:a statement for healthcare professionals from the American Heart Association[J].Circulation,1999,100:1134-1146.
6[3]Yeh ET.CRP as a mediator of disease[J].Circulation,2004,109:S11-14.
7[4]Khreiss T,Jozsef L,Potempa LA,et al.Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells[J].Circulation,2004,109:2016-2022.
8[5]Zouki C,Haas B,Chan JS,et al.Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion[J].J Immunol,2001,167:5355-5361.
9[6]Chavakis T,Bierhaus A,Nawroth PP.RAGE (receptor for advanced glycation end products):a central player in the inflammatory response[J].Microbes Infect,2004,6:1219-1225.
10[8]Nawroth P,Bierhaus A,Marrero M,et al.Atherosclerosis and restenosis:is there a role for RAGE[J].Curr Diab Rep,2005,5:11-16.
